glp 1 anesthesia glp-1 guidance news Guidelines for peri-operative care of GLP-1 RA and GIP patients 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations – GLP-1 agonists and anesthesia risk:

In addition to T2D, NAFLD is accompanied and complicated by several other extra-hepatic manifestations

Some studies suggest that peptides can have relatively short half-lives, sometimes only a few hours

Seek medical care for severe symptoms such as persistent vomiting, severe abdominal pain, dehydration, fainting, chest pain, shortness of breath, or confusion

Consult your healthcare provider if you experience persistent or severe side effects

Ipamorelin is purported to mimic the action of ghrelin, the hunger hormone, by targeting ghrelin receptors (GHS-R1a) in the anterior pituitary gland

Patients see reductions in visceral fat and improved metabolic markers over 3-6 months